Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons.
|
Cell Metab
|
2007
|
5.04
|
2
|
Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation.
|
Proc Natl Acad Sci U S A
|
2005
|
3.30
|
3
|
Lamins A and C but not lamin B1 regulate nuclear mechanics.
|
J Biol Chem
|
2006
|
3.02
|
4
|
Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase.
|
Arterioscler Thromb Vasc Biol
|
2009
|
2.99
|
5
|
Laminopathies and the long strange trip from basic cell biology to therapy.
|
J Clin Invest
|
2009
|
2.94
|
6
|
Prelamin A, Zmpste24, misshapen cell nuclei, and progeria--new evidence suggesting that protein farnesylation could be important for disease pathogenesis.
|
J Lipid Res
|
2005
|
2.88
|
7
|
Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes.
|
Proc Natl Acad Sci U S A
|
2005
|
2.85
|
8
|
GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries.
|
Cell Metab
|
2010
|
2.75
|
9
|
A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation.
|
J Clin Invest
|
2006
|
2.39
|
10
|
GPIHBP1: an endothelial cell molecule important for the lipolytic processing of chylomicrons.
|
Curr Opin Lipidol
|
2007
|
2.01
|
11
|
The acidic domain of GPIHBP1 is important for the binding of lipoprotein lipase and chylomicrons.
|
J Biol Chem
|
2008
|
1.91
|
12
|
Abnormal development of the cerebral cortex and cerebellum in the setting of lamin B2 deficiency.
|
Proc Natl Acad Sci U S A
|
2010
|
1.89
|
13
|
Targeting isoprenylcysteine methylation ameliorates disease in a mouse model of progeria.
|
Science
|
2013
|
1.88
|
14
|
Deficiencies in lamin B1 and lamin B2 cause neurodevelopmental defects and distinct nuclear shape abnormalities in neurons.
|
Mol Biol Cell
|
2011
|
1.86
|
15
|
The posttranslational processing of prelamin A and disease.
|
Annu Rev Genomics Hum Genet
|
2009
|
1.81
|
16
|
Abnormal patterns of lipoprotein lipase release into the plasma in GPIHBP1-deficient mice.
|
J Biol Chem
|
2008
|
1.73
|
17
|
Chylomicronemia elicits atherosclerosis in mice--brief report.
|
Arterioscler Thromb Vasc Biol
|
2009
|
1.72
|
18
|
Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia.
|
J Lipid Res
|
2009
|
1.67
|
19
|
Chylomicronemia with low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects.
|
Circ Cardiovasc Genet
|
2010
|
1.60
|
20
|
Highly conserved cysteines within the Ly6 domain of GPIHBP1 are crucial for the binding of lipoprotein lipase.
|
J Biol Chem
|
2009
|
1.54
|
21
|
Prelamin A farnesylation and progeroid syndromes.
|
J Biol Chem
|
2006
|
1.43
|
22
|
Progerin elicits disease phenotypes of progeria in mice whether or not it is farnesylated.
|
J Clin Invest
|
2008
|
1.40
|
23
|
Mouse models of the laminopathies.
|
Exp Cell Res
|
2007
|
1.40
|
24
|
Normal binding of lipoprotein lipase, chylomicrons, and apo-AV to GPIHBP1 containing a G56R amino acid substitution.
|
Biochim Biophys Acta
|
2007
|
1.39
|
25
|
An absence of both lamin B1 and lamin B2 in keratinocytes has no effect on cell proliferation or the development of skin and hair.
|
Hum Mol Genet
|
2011
|
1.35
|
26
|
Increased progerin expression associated with unusual LMNA mutations causes severe progeroid syndromes.
|
Hum Mutat
|
2007
|
1.34
|
27
|
Treatment with a farnesyltransferase inhibitor improves survival in mice with a Hutchinson-Gilford progeria syndrome mutation.
|
Biochim Biophys Acta
|
2007
|
1.33
|
28
|
An accumulation of non-farnesylated prelamin A causes cardiomyopathy but not progeria.
|
Hum Mol Genet
|
2010
|
1.26
|
29
|
Regulation of prelamin A but not lamin C by miR-9, a brain-specific microRNA.
|
Proc Natl Acad Sci U S A
|
2012
|
1.26
|
30
|
Direct synthesis of lamin A, bypassing prelamin a processing, causes misshapen nuclei in fibroblasts but no detectable pathology in mice.
|
J Biol Chem
|
2010
|
1.24
|
31
|
The expression of GPIHBP1, an endothelial cell binding site for lipoprotein lipase and chylomicrons, is induced by peroxisome proliferator-activated receptor-gamma.
|
Mol Endocrinol
|
2008
|
1.23
|
32
|
Adipose subtype-selective recruitment of TLE3 or Prdm16 by PPARγ specifies lipid storage versus thermogenic gene programs.
|
Cell Metab
|
2013
|
1.22
|
33
|
Cell nuclei spin in the absence of lamin b1.
|
J Biol Chem
|
2007
|
1.22
|
34
|
HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cells.
|
Proc Natl Acad Sci U S A
|
2007
|
1.20
|
35
|
The arrestin domain-containing 3 protein regulates body mass and energy expenditure.
|
Cell Metab
|
2011
|
1.19
|
36
|
GPIHBP1, a GPI-anchored protein required for the lipolytic processing of triglyceride-rich lipoproteins.
|
J Lipid Res
|
2008
|
1.18
|
37
|
Genetic studies on the functional relevance of the protein prenyltransferases in skin keratinocytes.
|
Hum Mol Genet
|
2010
|
1.13
|
38
|
Glycosylation of Asn-76 in mouse GPIHBP1 is critical for its appearance on the cell surface and the binding of chylomicrons and lipoprotein lipase.
|
J Lipid Res
|
2008
|
1.12
|
39
|
Protein farnesylation inhibitors cause donut-shaped cell nuclei attributable to a centrosome separation defect.
|
Proc Natl Acad Sci U S A
|
2011
|
1.10
|
40
|
New wrinkles in lipoprotein lipase biology.
|
Curr Opin Lipidol
|
2012
|
1.10
|
41
|
Targeted disruption of the idol gene alters cellular regulation of the low-density lipoprotein receptor by sterols and liver x receptor agonists.
|
Mol Cell Biol
|
2011
|
1.09
|
42
|
Eliminating the synthesis of mature lamin A reduces disease phenotypes in mice carrying a Hutchinson-Gilford progeria syndrome allele.
|
J Biol Chem
|
2008
|
1.09
|
43
|
Absence of progeria-like disease phenotypes in knock-in mice expressing a non-farnesylated version of progerin.
|
Hum Mol Genet
|
2010
|
1.09
|
44
|
Mutations in lipoprotein lipase that block binding to the endothelial cell transporter GPIHBP1.
|
Proc Natl Acad Sci U S A
|
2011
|
1.09
|
45
|
Binding preferences for GPIHBP1, a glycosylphosphatidylinositol-anchored protein of capillary endothelial cells.
|
Arterioscler Thromb Vasc Biol
|
2010
|
1.08
|
46
|
GPIHBP1, an endothelial cell transporter for lipoprotein lipase.
|
J Lipid Res
|
2011
|
1.08
|
47
|
Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis.
|
Arterioscler Thromb Vasc Biol
|
2012
|
1.08
|
48
|
Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs.
|
J Clin Invest
|
2014
|
1.07
|
49
|
Assessing the role of the glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) three-finger domain in binding lipoprotein lipase.
|
J Biol Chem
|
2011
|
1.07
|
50
|
Lipins, lipinopathies, and the modulation of cellular lipid storage and signaling.
|
Prog Lipid Res
|
2013
|
1.06
|
51
|
Caution! Analyze transcripts from conditional knockout alleles.
|
Transgenic Res
|
2008
|
1.04
|
52
|
IDOL stimulates clathrin-independent endocytosis and multivesicular body-mediated lysosomal degradation of the low-density lipoprotein receptor.
|
Mol Cell Biol
|
2013
|
1.04
|
53
|
PCSK9 function and physiology.
|
J Lipid Res
|
2008
|
1.03
|
54
|
Unexpected expression pattern for glycosylphosphatidylinositol-anchored HDL-binding protein 1 (GPIHBP1) in mouse tissues revealed by positron emission tomography scanning.
|
J Biol Chem
|
2010
|
1.03
|
55
|
Farnesylation of lamin B1 is important for retention of nuclear chromatin during neuronal migration.
|
Proc Natl Acad Sci U S A
|
2013
|
1.03
|
56
|
Protein farnesyltransferase inhibitors and progeria.
|
Trends Mol Med
|
2006
|
1.02
|
57
|
Investigating the purpose of prelamin A processing.
|
Nucleus
|
2011
|
1.01
|
58
|
Assessing the efficacy of protein farnesyltransferase inhibitors in mouse models of progeria.
|
J Lipid Res
|
2009
|
1.01
|
59
|
GPIHBP1 and lipolysis: an update.
|
Curr Opin Lipidol
|
2009
|
1.00
|
60
|
A potent HIV protease inhibitor, darunavir, does not inhibit ZMPSTE24 or lead to an accumulation of farnesyl-prelamin A in cells.
|
J Biol Chem
|
2008
|
0.99
|
61
|
Reciprocal metabolic perturbations in the adipose tissue and liver of GPIHBP1-deficient mice.
|
Arterioscler Thromb Vasc Biol
|
2011
|
0.99
|
62
|
A novel approach to tag and identify geranylgeranylated proteins.
|
Electrophoresis
|
2009
|
0.98
|
63
|
LINCing lamin B2 to neuronal migration: growing evidence for cell-specific roles of B-type lamins.
|
Nucleus
|
2011
|
0.98
|
64
|
Assessing mechanisms of GPIHBP1 and lipoprotein lipase movement across endothelial cells.
|
J Lipid Res
|
2012
|
0.98
|
65
|
A mouse monoclonal antibody specific for mouse apoB48 and apoB100 produced by immunizing "apoB39-only" mice with mouse apoB48.
|
Biochim Biophys Acta
|
2006
|
0.97
|
66
|
HIV-protease inhibitors block the enzymatic activity of purified Ste24p.
|
Biochem Biophys Res Commun
|
2008
|
0.97
|
67
|
Sterol regulatory element binding protein 1a regulates hepatic fatty acid partitioning by activating acetyl coenzyme A carboxylase 2.
|
Mol Cell Biol
|
2009
|
0.97
|
68
|
Modeling insertional mutagenesis using gene length and expression in murine embryonic stem cells.
|
PLoS One
|
2007
|
0.95
|
69
|
Are B-type lamins essential in all mammalian cells?
|
Nucleus
|
2011
|
0.95
|
70
|
Understanding the roles of nuclear A- and B-type lamins in brain development.
|
J Biol Chem
|
2012
|
0.93
|
71
|
Cholesterol intake modulates plasma triglyceride levels in glycosylphosphatidylinositol HDL-binding protein 1-deficient mice.
|
Arterioscler Thromb Vasc Biol
|
2010
|
0.93
|
72
|
Mouse lipin-1 and lipin-2 cooperate to maintain glycerolipid homeostasis in liver and aging cerebellum.
|
Proc Natl Acad Sci U S A
|
2012
|
0.92
|
73
|
PCSK9 function and physiology.
|
J Lipid Res
|
2008
|
0.92
|
74
|
Lipoprotein size and susceptibility to atherosclerosis--insights from genetically modified mouse models.
|
Curr Drug Targets
|
2008
|
0.92
|
75
|
Modulation of LMNA splicing as a strategy to treat prelamin A diseases.
|
J Clin Invest
|
2016
|
0.90
|
76
|
Inhibitors of protein geranylgeranyltransferase-I lead to prelamin A accumulation in cells by inhibiting ZMPSTE24.
|
J Lipid Res
|
2012
|
0.88
|
77
|
Chylomicronemia mutations yield new insights into interactions between lipoprotein lipase and GPIHBP1.
|
Hum Mol Genet
|
2012
|
0.87
|
78
|
Targeting protein prenylation in progeria.
|
Sci Transl Med
|
2013
|
0.85
|
79
|
Severe hepatocellular disease in mice lacking one or both CaaX prenyltransferases.
|
J Lipid Res
|
2011
|
0.85
|
80
|
Genetic analyses of the role of RCE1 in RAS membrane association and transformation.
|
Methods Enzymol
|
2008
|
0.83
|
81
|
Sphingosine-1-phosphate lyase expression in embryonic and adult murine tissues.
|
J Lipid Res
|
2012
|
0.83
|
82
|
Nuclear lamins in the brain - new insights into function and regulation.
|
Mol Neurobiol
|
2012
|
0.82
|
83
|
Increasing the length of progerin's isoprenyl anchor does not worsen bone disease or survival in mice with Hutchinson-Gilford progeria syndrome.
|
J Lipid Res
|
2008
|
0.80
|
84
|
Lowering plasma cholesterol by raising LDL receptors--revisited.
|
N Engl J Med
|
2012
|
0.80
|
85
|
New Lmna knock-in mice provide a molecular mechanism for the 'segmental aging' in Hutchinson-Gilford progeria syndrome.
|
Hum Mol Genet
|
2013
|
0.78
|
86
|
LDL and cAMP cooperate to regulate the functional expression of the LRP in rat ovarian granulosa cells.
|
J Lipid Res
|
2006
|
0.76
|
87
|
Do lamin B1 and lamin B2 have redundant functions?
|
Nucleus
|
2014
|
0.75
|